AZN vs JNJ: Which Stock is Better?

Side-by-side comparison of AstraZeneca PLC and Johnson & Johnson in 2026

Comparison Updated:

AZN

AstraZeneca PLC

JNJ

Johnson & Johnson

$253.04

Key Metrics Comparison

MetricAZNJNJWinner
Market Cap$288.38B$375.37BJNJ
P/E Ratio28.0017.35JNJ
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze AZN

Full quant analysis

Analyze JNJ

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AZN or JNJ a better investment?

Comparing AZN and JNJ: AstraZeneca PLC has a market cap of $288.38B while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AZN and JNJ?

AZN (AstraZeneca PLC) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AZN or JNJ?

Based on P/E ratios, JNJ trades at a lower multiple (17.4x vs 28.0x).

Which is growing faster: AZN or JNJ?

Both AZN and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: AZN or JNJ?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: AZN or JNJ?

Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $288.38B for AZN.

Should I buy AZN or JNJ in 2026?

Both AZN and JNJ have investment merit. AZN trades at $N/A while JNJ trades at $253.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AZN and JNJ stock?

Key differences: Market Cap ($288.38B vs $375.37B), P/E Ratio (28.0x vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy AZN or JNJ in 2026?

The choice between AZN and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between AZN and JNJ?

AZN (AstraZeneca PLC) has a market cap of $288.38B, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.

Popular Stock Comparisons